🇺🇸 FDA
Patent

US 9914940

Targeted integration into the PPP1R12C locus

granted A61PA61P43/00

Quick answer

US patent 9914940 (Targeted integration into the PPP1R12C locus) held by Sangamo Therapeutics, Inc. expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P43/00